Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 2003

View Archived Issues

Role for NMDA receptor antagonists in pain

New data on sertraline in GAD, panic disorder and postpartum depression

Potential use of SM-31900 for treating acute brain ischemia

Pharmacokinetics of HBOC-201 in surgical patients

Effects of etiprednol dicloacetate on the HPA axis

Stiripentol added to carbamazepine effective in refractory partial epilepsy

CVT-3146: tolerability and pharmacokinetics in man

Histone deacetylase inhibitors derived from SAHA presented at ACS meeting

New PTP1B inhibitors in early development at Abbott

Aventis presents four related series of anorectic compounds

Novel N-type calcium channel antagonists prepared and tested at Ajinomoto

Nonsteroidal metal chelators with affinity for steroid receptors for cancer diagnosis and treatment

Nippon Chemiphar claims PPARdelta agonists with utility in metabolic disorders

Hepavir B enters clinical testing

Periostat approved in Canada

Renagel receives NHI drug price listing in Japan

Celmed focuses development activities on Theralux and Neuro technology platforms

Postmarketing Visicol study begins patient treatment

APT-070 enters phase IIa trials

Prous Science announces publication of state-of-the-art review: acne vulgaris

DA-8159 is well tolerated in healthy volunteers and without significant hemodynamic effects

Thirty-five new products reach their first markets in 2002

Potent CCR3 receptor antagonists with potential in chronic inflammation

Merck reports the identification of a surprisingly potent and selective thrombin inhibitor

Thienopyridines targeting VEGFR tyrosine kinase presented by Pfizer

Safety, tolerability and pharmacokinetics of single and multiple oral doses of LY-450108

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...